CTNNB1 gene alterations in HCC are associated with less lymphocytic infiltration [25] and decreased levels of CCL5, which recruits antigen-specific CD8+ T cells, resulting in poor immunogenicity and resistance to ICI therapy [11,26]. This evidence concerns the gene CCL5 and hepatocellular carcinoma.